Tags

Type your tag names separated by a space and hit enter

Yellow fever: epidemiology and prevention.
Clin Infect Dis. 2007 Mar 15; 44(6):850-6.CI

Abstract

Yellow fever continues to occur in regions of Africa and South America, despite the availability of effective vaccines. Recently, some cases of severe neurologic disease and multiorgan system disease have been described in individuals who received yellow fever vaccine. These events have focused attention on the need to define criteria for judicious use of yellow fever vaccine and to describe the spectrum of adverse events that may be associated with yellow fever vaccine. Describing host factors that would increase risk of these events and identifying potential treatment modalities for yellow fever and yellow fever vaccine-associated adverse events are subjects of intense investigation.

Authors+Show Affiliations

Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA. ebarnett@bu.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

17304460

Citation

Barnett, Elizabeth D.. "Yellow Fever: Epidemiology and Prevention." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 44, no. 6, 2007, pp. 850-6.
Barnett ED. Yellow fever: epidemiology and prevention. Clin Infect Dis. 2007;44(6):850-6.
Barnett, E. D. (2007). Yellow fever: epidemiology and prevention. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 44(6), 850-6.
Barnett ED. Yellow Fever: Epidemiology and Prevention. Clin Infect Dis. 2007 Mar 15;44(6):850-6. PubMed PMID: 17304460.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Yellow fever: epidemiology and prevention. A1 - Barnett,Elizabeth D, Y1 - 2007/02/01/ PY - 2006/09/15/received PY - 2006/11/20/accepted PY - 2007/2/17/pubmed PY - 2007/3/8/medline PY - 2007/2/17/entrez SP - 850 EP - 6 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin Infect Dis VL - 44 IS - 6 N2 - Yellow fever continues to occur in regions of Africa and South America, despite the availability of effective vaccines. Recently, some cases of severe neurologic disease and multiorgan system disease have been described in individuals who received yellow fever vaccine. These events have focused attention on the need to define criteria for judicious use of yellow fever vaccine and to describe the spectrum of adverse events that may be associated with yellow fever vaccine. Describing host factors that would increase risk of these events and identifying potential treatment modalities for yellow fever and yellow fever vaccine-associated adverse events are subjects of intense investigation. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/17304460/Yellow_fever:_epidemiology_and_prevention_ L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/511869 DB - PRIME DP - Unbound Medicine ER -